These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1075 related articles for article (PubMed ID: 30457164)
1. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2. Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164 [TBL] [Abstract][Full Text] [Related]
2. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis. Wu X; Kong C; Wu Y Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558 [TBL] [Abstract][Full Text] [Related]
3. lncRNA CERS6-AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR-125a-5p to upregulate BAP1 expression. Yan L; Li K; Feng Z; Zhang Y; Han R; Ma J; Zhang J; Wu X; Liu H; Jiang Y; Zhang Y; Zhu Y Mol Carcinog; 2020 Oct; 59(10):1199-1208. PubMed ID: 32808708 [TBL] [Abstract][Full Text] [Related]
4. LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer. Ma Y; Bu D; Long J; Chai W; Dong J J Cell Physiol; 2019 Mar; 234(3):2880-2894. PubMed ID: 30203615 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis. Liu Y; Wei G; Ma Q; Han Y Thorac Cancer; 2020 Feb; 11(2):394-407. PubMed ID: 31901156 [TBL] [Abstract][Full Text] [Related]
6. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p. Zang H; Li Y; Zhang X; Huang G Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273 [TBL] [Abstract][Full Text] [Related]
7. LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis. Qiu Z; Pan XX; You DY Neoplasma; 2020 Jul; 67(4):871-879. PubMed ID: 32386483 [TBL] [Abstract][Full Text] [Related]
8. Circular RNA 0007255 regulates the progression of breast cancer through miR-335-5p/SIX2 axis. Jia Q; Ye L; Xu S; Xiao H; Xu S; Shi Z; Li J; Chen Z Thorac Cancer; 2020 Mar; 11(3):619-630. PubMed ID: 31962380 [TBL] [Abstract][Full Text] [Related]
9. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA ZBED3-AS1 restrains breast cancer progression by targeting the microRNA-513a-5p/KLF6 axis. Fu A; Yu Z; Zhang E; Song J Thorac Cancer; 2021 Oct; 12(20):2719-2731. PubMed ID: 34427978 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway. Gao J; Dai C; Yu X; Yin XB; Zhou F J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108 [TBL] [Abstract][Full Text] [Related]
12. Deletion of Meng Q; Wang L; Lv Y; Wu J; Shi W Cancer Biother Radiopharm; 2021 Feb; 36(1):23-35. PubMed ID: 32319789 [No Abstract] [Full Text] [Related]
13. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer. Sun J; Min H; Yu L; Yu G; Shi Y; Sun J Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312 [TBL] [Abstract][Full Text] [Related]
14. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells. Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2. Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524 [TBL] [Abstract][Full Text] [Related]
16. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p. Hou S; Lin Q; Guan F; Lin C J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424 [TBL] [Abstract][Full Text] [Related]
17. Identification of lncRNA NEAT1/miR-21/RRM2 axis as a novel biomarker in breast cancer. Quan D; Chen K; Zhang J; Guan Y; Yang D; Wu H; Wu S; Lv L J Cell Physiol; 2020 Apr; 235(4):3372-3381. PubMed ID: 31621912 [TBL] [Abstract][Full Text] [Related]
18. MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells. Zhao YS; Yang WC; Xin HW; Han JX; Ma SG Yonsei Med J; 2019 Feb; 60(2):148-157. PubMed ID: 30666836 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA Down syndrome cell adhesion molecule-anti-sense 1 promotes gastric carcinoma cell proliferation and migration by regulating the miR-204/TPT1 axis. Wang N; Yang Y; Jia GZ; Wang K; Zhou S; Zhang B; Zhang ZS; Qiao Q; He XL Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S187-S195. PubMed ID: 34372727 [No Abstract] [Full Text] [Related]
20. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. Bai T; Liu Y; Li B IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]